Search research articles
Contact Us
Filters
Showing results (201-210 of 420) with videos related to
Page
of 42
Sort By:
The Journal of Infection
|
May 1, 2014
Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012)
Helio S Sader, David J Farrell, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy
|
February 12, 2014
Antimicrobial activity of ceftaroline tested against drug-resistant subsets of Streptococcus pneumoniae from U.S. medical centers
Robert K Flamm, Helio S Sader, David J Farrell, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 15, 2021
Tedizolid activity against a multicentre worldwide collection of Staphylococcus aureus and Streptococcus pneumoniae recovered from patients with pneumonia (2017-2019)
Cecilia G Carvalhaes, Helio S Sader, Paul R Rhomberg, et al.
Diagnostic Microbiology and Infectious Disease
|
July 24, 2012
Macrolide and tetracycline resistance among Moraxella catarrhalis isolates from 2009 to 2011
Robert K Flamm, Helio S Sader, David J Farrell, et al.
Antimicrobial Agents and Chemotherapy
|
July 29, 2005
Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains
Helio S Sader, Thomas R Fritsche, Koné Kaniga, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 2017
WCK 5222 (Cefepime-Zidebactam) Antimicrobial Activity against Clinical Isolates of Gram-Negative Bacteria Collected Worldwide in 2015
Helio S Sader, Mariana Castanheira, Michael Huband, et al.
Jac-Antimicrobial Resistance
|
March 27, 2023
Aztreonam/avibactam activity against a large collection of carbapenem-resistant Enterobacterales (CRE) collected in hospitals from Europe, Asia and Latin America (2019-21)
Helio S Sader, Mariana Castanheira, John H Kimbrough, et al.
Antimicrobial Agents and Chemotherapy
|
December 5, 2025
Activity of aztreonam-avibactam, cefiderocol, and cefepime-taniborbactam against a global collection of genetically characterized metallo-β-lactamase-producing Enterobacterales
Mariana Castanheira, John H Kimbrough, Gina M Morgan, et al.
The Journal of Antimicrobial Chemotherapy
|
November 9, 2012
Antimicrobial activity of the novel polymyxin derivative NAB739 tested against Gram-negative pathogens
Martti Vaara, Helio S Sader, Paul R Rhomberg, et al.
Antimicrobial Agents and Chemotherapy
|
August 23, 2017
Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016
Helio S Sader, Mariana Castanheira, Dee Shortridge, et al.
Page
of 42
Search research articles
Search
Showing results (201-210 of 420) with videos related to
Sort By:
Page
of 42
The Journal of Infection
|
May 1, 2014
Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012)
Helio S Sader, David J Farrell, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy
|
February 12, 2014
Antimicrobial activity of ceftaroline tested against drug-resistant subsets of Streptococcus pneumoniae from U.S. medical centers
Robert K Flamm, Helio S Sader, David J Farrell, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 15, 2021
Tedizolid activity against a multicentre worldwide collection of Staphylococcus aureus and Streptococcus pneumoniae recovered from patients with pneumonia (2017-2019)
Cecilia G Carvalhaes, Helio S Sader, Paul R Rhomberg, et al.
Diagnostic Microbiology and Infectious Disease
|
July 24, 2012
Macrolide and tetracycline resistance among Moraxella catarrhalis isolates from 2009 to 2011
Robert K Flamm, Helio S Sader, David J Farrell, et al.
Antimicrobial Agents and Chemotherapy
|
July 29, 2005
Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains
Helio S Sader, Thomas R Fritsche, Koné Kaniga, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 2017
WCK 5222 (Cefepime-Zidebactam) Antimicrobial Activity against Clinical Isolates of Gram-Negative Bacteria Collected Worldwide in 2015
Helio S Sader, Mariana Castanheira, Michael Huband, et al.
Jac-Antimicrobial Resistance
|
March 27, 2023
Aztreonam/avibactam activity against a large collection of carbapenem-resistant Enterobacterales (CRE) collected in hospitals from Europe, Asia and Latin America (2019-21)
Helio S Sader, Mariana Castanheira, John H Kimbrough, et al.
Antimicrobial Agents and Chemotherapy
|
December 5, 2025
Activity of aztreonam-avibactam, cefiderocol, and cefepime-taniborbactam against a global collection of genetically characterized metallo-β-lactamase-producing Enterobacterales
Mariana Castanheira, John H Kimbrough, Gina M Morgan, et al.
The Journal of Antimicrobial Chemotherapy
|
November 9, 2012
Antimicrobial activity of the novel polymyxin derivative NAB739 tested against Gram-negative pathogens
Martti Vaara, Helio S Sader, Paul R Rhomberg, et al.
Antimicrobial Agents and Chemotherapy
|
August 23, 2017
Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016
Helio S Sader, Mariana Castanheira, Dee Shortridge, et al.
Page
of 42